# Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia

> **NCT00005808** · PHASE1 · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 54 (actual)

## Conditions studied

- Cervical Cancer
- Cervical Intraepithelial Neoplasia Grade 2
- Cervical Intraepithelial Neoplasia Grade 3

## Interventions

- **DRUG:** motexafin lutetium
- **DRUG:** photodynamic therapy
- **PROCEDURE:** loop electrosurgical excision procedure
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00005808
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-12
- **Primary completion:** 2004-04
- **Final completion:** —
- **Target enrollment:** 54 (ACTUAL)
- **Why stopped:** Administratively complete.
- **Last updated:** 2013-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005808, "Photodynamic Therapy Using Lutetium Texaphyrin in Treating Patients With Cervical Intraepithelial Neoplasia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00005808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*